Infectious Disease Alert – January 1, 2011
January 1, 2011
View Issues
-
Special Feature: Oral Rehydration Therapy Shows Effectiveness in Controlling Cholera in Haiti
In 1854, london was rocked by a cholera epidemic that killed approximately 10,000 people. Using what are now considered classical epidemiological methods, Dr. John Snow traced the source of at least 500 of the infections to a single water pump at Broad Street, validating his theory that cholera was a water-borne disease 29 years before the etiologic agent was discovered by Robert Koch; removing the pump handle stopped the outbreak in that area. -
Abstract & Commentary: Detecting Human Metapneumovirus in Young Children
A prospective study from November 2001 through October 2005 in Israel collected nasopharyngeal wash specimens from children < 5 years who were diagnosed with community-acquired alveolar pneumonia. -
Abstract & Commentary: Endotipsitis — Difficult to Diagnose, Difficult to Treat
I was asked earlier this week to see a patient with candidemia. The patient had severe cirrhosis and had previously had placement of a transjugular intrahepatic portosystemic shunt (TIPS) for control of complications of portal hypertension. -
Abstract & Commentary: Cranberry Juice Prophylaxis for UTIs: A Reason for Skepticism?
Recurrent urinary tract infections (UTI) in females is a common and distressing clinical problem. -
Abstract & Commentary: Should We Adopt a Pre-exposure Prophylaxis Approach for HIV Prevention?
In this study, 2,499 hiv-seronegative men or transgender females who have sex with men (MSM) were randomized to daily TDF/FTC vs. placebo in a multicenter, controlled trial with clinical sites in North America, Latin America, Thailand, and Africa. -
Abstract & Commentary: Revised Guidelines for Perinatal Group B Streptococcal Disease
Group B streptococcal (GBS) disease is the leading cause of early-onset neonatal sepsis (within the first week of life) in the United States. -
Updates By Carol A. Kemper, MD, FACP
These authors examined the use of antimicrobials for skin and soft tissue infection (SSTI), comparing the presentation, complications, microbial results and outcomes of adults hospitalized at Denver Health Medical Center. -
Pharmacology Watch: Rivaroxaban: Another Warfarin Replacement
In this issue: Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions. -
Clinical Briefs in Primary Care supplement